跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,059 条关于
“Squadron Capital Management”
全部
28,059
临床试验
17,482
药物
155
机构
290
资讯
10,132
10个月前
Relmada Therapeutics Raises $100 Million to Advance Oncology and CNS Pipeline
10个月前
Cybin Closes $175 Million Financing to Advance Phase 3 Psychedelic Depression Treatment
去年
Rezolute Secures $90 Million in Public Offering to Advance Rare Disease Therapies
9个月前
Pasithea Therapeutics Secures $60 Million Funding to Advance MEK Inhibitor for Neurofibromatosis Treatment
5个月前
Sol-Gel Secures Patent Extension for Patidegib Until 2044, Raises $33.1M to Advance Gorlin Syndrome Trial
2个月前
Jasper Therapeutics Merges with Kira Pharmaceuticals, Secures $132 Million to Advance Complement and Immunology Pipeline
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
6个月前
Superstring Capital Management Invests $6.84 Million in CNS Drug Developer Axsome Therapeutics
6个月前
ACT Capital Management Invests $8 Million in TG Therapeutics Despite 30% Stock Decline
9个月前
Tang Capital Management Invests $56.8 Million in Celcuity Following Positive Phase 3 Gedatolisib Results
第 1 页，共 1014 页
上一页
下一页
